Drug,Condition,Recommendation,Rationale
Cilostazol,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Aspirin,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Diclofenac,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Diflunisal,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Etodolac,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Fenoprofen,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Ibuprofen,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Ketoprofen,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Meclofenamate,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Mefenamic Acid,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Meloxicam,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Nabumetone,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Naproxen,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Oxaprozin,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Piroxicam,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Sulindac,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Tolmetin,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Celecoxib,Heart failure with preserved ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Cilostazol,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Diltiazem,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Verapamil,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Aspirin,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Diclofenac,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Diflunisal,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Etodolac,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Fenoprofen,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Ibuprofen,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Ketoprofen,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Meclofenamate,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Mefenamic Acid,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Meloxicam,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Nabumetone,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Naproxen,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Oxaprozin,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Piroxicam,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Sulindac,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Tolmetin,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Celecoxib,Heart failure with reduced ejection fraction,Avoid,"Potential to promote fluid retention and/or exacerbate heart failure (NSAIDs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)"
Pioglitazone,"Heart failure with reduced ejection fraction, asymptomatic",Use with caution,Potential to promote fluid retention and/or exacerbate heart failure
Rosiglitazone,"Heart failure with reduced ejection fraction, asymptomatic",Use with caution,Potential to promote fluid retention and/or exacerbate heart failure
Dronedarone,"Heart failure with reduced ejection fraction, asymptomatic",Use with caution,Potential to promote fluid retention and/or exacerbate heart failure
Pioglitazone,"Heart failure with preserved ejection fraction, asymptomatic",Use with caution,Potential to promote fluid retention and/or exacerbate heart failure
Rosiglitazone,"Heart failure with preserved ejection fraction, asymptomatic",Use with caution,Potential to promote fluid retention and/or exacerbate heart failure
Dronedarone,"Heart failure with preserved ejection fraction, asymptomatic",Use with caution,Potential to promote fluid retention and/or exacerbate heart failure
Donepezil,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia
Rivastigmine,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia
Galantamine,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia
Tacrine,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia
Doxazosin,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia
Prazosin,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia
Terazosin,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia
Amitriptyline,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia
Imipramine,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia
Clomipramine,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia
Trimipramine,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia
Doxepin,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia
Chlorpromazine,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia
Thioridazine,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia
Olanzapine,Syncope,Avoid,AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary TCAs and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia
Disopyramide,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Pyrilamine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Triprolidine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Amitriptyline,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Amoxapine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Clomipramine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Desipramine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Doxepin (>6 mg),Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Darifenacin,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Imipramine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Fesoterodine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Nortriptyline,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Flavoxate,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Paroxetine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Oxybutynin,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Protriptyline,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Solifenacin,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Trimipramine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Tolterodine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Trospium,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Prochlorperazine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Promethazine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Benztropine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Trihexyphenidyl,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Brompheniramine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Carbinoxamine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Chlorpromazine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Chlorpheniramine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Clozapine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Clemastine/Loxapine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Cyproheptadine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Olanzapine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Dexbrompheniramine/Perphenazine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Dexchlorpheniramine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Thioridazine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Dimenhydrinate,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Trifluoperazine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Diphenhydramine (oral),Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Doxylamine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Hydroxyzine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Atropine (excludes ophthalmic),Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Meclizine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Belladonna alkaloids,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Clidinium/Chlordiazepoxide,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Scopolamine (excludes ophthalmic),Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Dicyclomine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Homatropine (excludes ophthalmic),Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Hyoscyamine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Cyclobenzaprine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Methscopolamine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Orphenadrine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Propantheline,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Alprazolam,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Estazolam,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Lorazepam,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Oxazepam,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Temazepam,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Triazolam,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Chlordiazepoxide,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Clonazepam,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Clorazepate,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Diazepam,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Flurazepam,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Quazepam,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Chlorpromazine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Droperidol,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Fluphenazine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Haloperidol,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Loxapine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Perphenazine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Pimozide,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Prochlorperazine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Thioridazine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Thiothixene,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Trifluoperazine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Aripiprazole,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Asenapine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Clozapine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Iloperidone,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Lurasidone,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Olanzapine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Paliperidone,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Quetiapine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Risperidone,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Ziprasidone,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Pimavanserin,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Hydrocortisone,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Cortisone,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Betamethasone,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Prednisone,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Prenisolone,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Triamcinolone,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Methylprednisolone,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Dexamethasone,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Ethamethasoneb,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Cimetidine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Famotidine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Nizatidine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Ranitidine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Meperidine,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Eszopiclone,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Zaleplon,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Zolpidem,Delirium,Avoid,"Avoid in older adults with or at high risk of delirium because of potential of inducing or worsening delirium.
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Disopyramide,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Pyrilamine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Triprolidine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Amitriptyline,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Amoxapine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Clomipramine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Desipramine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Doxepin (>6 mg),Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Darifenacin,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Imipramine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Fesoterodine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Nortriptyline,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Flavoxate,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Paroxetine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Oxybutynin,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Protriptyline,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Solifenacin,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Trimipramine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Tolterodine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Trospium,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Prochlorperazine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Promethazine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Benztropine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Trihexyphenidyl,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Brompheniramine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Carbinoxamine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Chlorpromazine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Chlorpheniramine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Clozapine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Clemastine/Loxapine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Cyproheptadine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Olanzapine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Dexbrompheniramine/Perphenazine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Dexchlorpheniramine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Thioridazine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Dimenhydrinate,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Trifluoperazine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Diphenhydramine (oral),Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Doxylamine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Hydroxyzine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Atropine (excludes ophthalmic),Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Meclizine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Belladonna alkaloids,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Clidinium/Chlordiazepoxide,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Scopolamine (excludes ophthalmic),Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Dicyclomine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Homatropine (excludes ophthalmic),Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Hyoscyamine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Cyclobenzaprine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Methscopolamine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Orphenadrine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Propantheline,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Alprazolam,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Estazolam,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Lorazepam,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Oxazepam,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Temazepam,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Triazolam,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Chlordiazepoxide,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Clonazepam,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Clorazepate,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Diazepam,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Flurazepam,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Quazepam,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Eszopiclone,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Zaleplon,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Zolpidem,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Chlorpromazine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Droperidol,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Fluphenazine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Haloperidol,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Loxapine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Perphenazine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Pimozide,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Prochlorperazine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Thioridazine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Thiothixene,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Trifluoperazine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Aripiprazole,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Asenapine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Clozapine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Iloperidone,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Lurasidone,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Olanzapine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Paliperidone,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Quetiapine,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Risperidone,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Ziprasidone,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Pimavanserin,Dementia or cognitive impairment,Avoid,"Avoid because of adverse CNS effects
Avoid antipsychotics for behavioral problems of dementia and/or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. Antipsychotics are associated with greater risk of cerebrovascular accident (stroke) and mortality in persons with dementia."
Phenytoin,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Valproic Acid,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Phenobarbital,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Lamotrigine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Carbamazepine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Topiramate,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Oxcarbazepine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Zonisamide,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Gabapentin,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Levetiracetam,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Pregabalin,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Clonazepam,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Lacosamide,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Rufinamide,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Vigabatrin,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Chlorpromazine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Droperidol,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Fluphenazine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Haloperidol,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Loxapine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Perphenazine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Pimozide,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Prochlorperazine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Thioridazine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Thiothixene,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Trifluoperazine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Aripiprazole,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Asenapine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Clozapine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Iloperidone,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Lurasidone,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Olanzapine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Paliperidone,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Quetiapine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Risperidone,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Ziprasidone,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Pimavanserin,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Alprazolam,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Estazolam,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Lorazepam,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Oxazepam,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Temazepam,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Triazolam,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Chlordiazepoxide,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Clonazepam,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Clorazepate,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Diazepam,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Flurazepam,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Quazepam,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Eszopiclone,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Zaleplon,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Zolpidem,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Amitriptyline,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Amoxapine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Clomipramine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Desipramine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Doxepin,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Imipramine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Nortriptyline,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Paroxetine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Protriptyline,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Trimipramine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Citalopram,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Escitalopram,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Fluoxetine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Paroxetine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Sertraline,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Desvenlafaxine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Duloxetine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Levomilnacipran,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Milnacipran,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Venlafaxine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Opium,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Heroin,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Codeine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Oxycodone,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Hydrocodone,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Tramadol,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Morphine,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Hydromorphone,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Fentanyl,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Carfentanil,History of falls or fractures,Avoid,"May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones.
If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others."
Metoclopramide,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Prochlorperazine,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Promethazine,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Chlorpromazine,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Droperidol,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Fluphenazine,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Haloperidol,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Loxapine,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Perphenazine,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Pimozide,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Prochlorperazine,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Thioridazine,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Thiothixene,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Trifluoperazine,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Aripiprazole,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Asenapine,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Iloperidone,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Lurasidone,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Olanzapine,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Paliperidone,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Risperidone,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Ziprasidone,Parkinson Disease,Avoid,"Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms.
Exceptions: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to that of placebo in five trials and to that of clozapine in two others."
Aspirin (>325 mg/day),History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers
Diclofenac,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers
Diflunisal,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers
Etodolac,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers
Fenoprofen,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers
Ibuprofen,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers
Ketoprofen,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers
Meclofenamate,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers
Mefenamic acid,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers
Meloxicam,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers
Nabumetone,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers
Naproxen,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers
Oxaprozin,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers
Piroxicam,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers
Sulindac,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers
Tolmetin,History of gastric or duodenal ulcers,Avoid unless other alternatives are not effective and patient can take gastroprotective agent (i.e. proton-pump inhibitor or misoprostol),May exacerbate existing ulcers or cause new/additional ulcers
Aspirin,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function
Diclofenac,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function
Diflunisal,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function
Etodolac,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function
Fenoprofen,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function
Ibuprofen,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function
Ketoprofen,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function
Meclofenamate,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function
Mefenamic acid,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function
Meloxicam,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function
Nabumetone,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function
Naproxen,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function
Oxaprozin,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function
Piroxicam,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function
Sulindac,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function
Tolmetin,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function
Celecoxib,Chronic Kidney Disease (stage 4 or higher - creatinine clearance <30 mL/min),Avoid,May increase risk of acute kidney injury and further decline of renal function
Estradiol/Levonorgestrel,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers)
Estradiol/Northindrone,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers)
Estradiol/Drospirenone,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers)
Ospemifene,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers)
Estradiol/Norgestimate,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers)
Estrogen/Medroxyprogesterone,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers)
Estropipate,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers)
Estrogen,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers)
Estradiol,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers)
Doxazosin,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers)
Prazosin,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers)
Terazosin,Urinary incontinence (women),Avoid in women (excludes intravaginal estrogen),Lack of efficacy (oral estrogen) and aggravation of incontinence (alpha-1 blockers)
Disopyramide,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Pyrilamine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Triprolidine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Amitriptyline,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Amoxapine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Clomipramine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Desipramine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Doxepin (>6 mg),Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Darifenacin,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Imipramine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Fesoterodine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Nortriptyline,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Flavoxate,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Paroxetine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Oxybutynin,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Protriptyline,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Solifenacin,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Trimipramine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Tolterodine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Trospium,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Prochlorperazine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Promethazine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Benztropine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Trihexyphenidyl,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Brompheniramine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Carbinoxamine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Chlorpromazine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Chlorpheniramine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Clozapine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Clemastine/Loxapine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Cyproheptadine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Olanzapine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Dexbrompheniramine/Perphenazine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Dexchlorpheniramine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Thioridazine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Dimenhydrinate,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Trifluoperazine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Diphenhydramine (oral),Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Doxylamine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Hydroxyzine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Atropine (excludes ophthalmic),Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Meclizine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Belladonna alkaloids,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Clidinium/Chlordiazepoxide,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Scopolamine (excludes ophthalmic),Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Dicyclomine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Homatropine (excludes ophthalmic),Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Hyoscyamine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Cyclobenzaprine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Methscopolamine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Orphenadrine,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
Propantheline,Benign prostatic hyperplasia (BPH),Avoid in men unless antimuscarinics are being used for urinary incontinence,May decrease urinary flow and cause urinary retention
